What are the benefits of DHEA?
Anna Cabeca, DO, FACOG, discusses dehydroepiandrosterone and associated misunderstandings.
Unlocking the power of oxytocin
Explore the research on oxytocin's role beyond labor and bonding as Anna Cabeca, DO, FACOG, triple board certified ob-gyn, sheds light on its impact on longevity, sexual health, and overall well-being at the A4M conference in Las Vegas.
Obstetrics and Gynecology: 2023 year in review
The digital editor for Contemporary OB/GYN offers his thoughts on trends and news in women’s health this past year.
Deciding the best treatment for uterine fibroids
Jay Goldberg, MD, ob-gyn at Einstein Medical Center of Philadelphia, outlines treatment options for uterine fibroids in patients with different needs.
Clinical pearls of pediatric dermatology
Toby Maurer, MD, professor at University of California, San Francisco, discusses dermatologic conditions commonly seen in pediatric patients.
Approaching inflammatory vulvovaginal diseases
Toby Maurer, MD, professor at University of California, San Francisco, discusses the clinical pearls of inflammatory vulvovaginal conditions and treatment.
Managing skin health in women
Toby Maurer, MD, professor at University of California, San Francisco, discusses common skin conditions seen in female patients, along with the best methods of treating these conditions.
Clinical pearls of abnormal uterine bleeding management
Jay Goldberg, MD, ob-gyn at Einstein Medical Center of Philadelphia, discusses treatment paradigms which can help clinicians manage abnormal uterine bleeding in their patients.
How to address sexual dysfunction during menopause
James A. Simon, MD, discusses how clinicians can help menopausal women manage sexual dysfunction.
Hot flashes poorly impact sleep quality
James A Simon, MD, discusses the link between hot flashes and poor sleep quality, and how clinicians can help their patients manage sleep disorders.
What's new in endometrium care?
Steven R. Goldstein, MD, discusses holes in clinicians' understanding of the endometrium, and how these knowledge gaps can be remedied.
How to manage bone health in midlife women
Michael E. Lewiecki, MD, discusses risk factors of osteoporosis in midlife women, and how clinicians can measure and manage bone health.
Mary Jane Minkin, MD, discusses The Menopause Society 2023 Annual Meeting
Mary Jane Minkin, MD, FACOG, MSCP, discusses key takeaways from The Menopause Society 2023 Annual Meeting, held in Philadelphia, Pennsylvania from September 27-30.
Highlights from The Menopause Society 2023 Annual Meeting
Barbara A. Dehn, NP, Vice President of Women’s Health at Peppy Health, discusses topics presented at The Menopause Society which will help her in her practice.
How fezolinetant changes management of hot flashes
Nanette F. Santoro, MD, chair of OBGYN at the University of Colorado School of Medicine, discusses new research on fezolinetant as a nonhormone method for managing hot flashes at the 2023 Menopause Society Annual Meeting.
Future Directions in Recurrent Vulvovaginal Candidiasis Care
Michael L. Krychman, MD, and Jack D. Sobel, MD, discuss the importance of awareness and education about RVVC, particularly given the impact of symptoms on patients’ psychosocial and sexual behavior.
Tips for Treatment Selection in Recurrent Vulvovaginal Candidiasis
Michael L. Krychman, MD, and Jack D. Sobel, MD, discuss the practical challenges of access to newer, FDA-approved medications for RVVC and how the third-party reimbursement landscape may take shape in coming years.
How Emerging Agents Will Shape the Treatment Landscape for Recurrent Vulvovaginal Candidiasis
Experts explore the availability and cost as well as other unanswered questions regarding emerging agents for the treatment of RVVC.
Exploring Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis
Michael L. Krychman, MD, and Jack D. Sobel, MD, review the mechanisms of ibrexafungerp and how it might fit in the treatment spectrum for RVVC.
The Role of Oteseconazole in the Treatment of Recurrent Vulvovaginal Candidiasis
Michael L. Krychman, MD, and Jack D. Sobel, MD, review the clinical implications of the recent approval of oteseconazole, which has been shown to be efficacious and well tolerated in RVVC treatment.
The Trajectory of Treatment for Recurrent Vulvovaginal Candidiasis
Thought leaders discuss the history of RVVC treatment, including the use of unapproved topical antifungals and the shortcomings of fluconazole.
Awareness and Education Regarding Recurrent Vulvovaginal Candidiasis
Michael L. Krychman, MD, and Jack D. Sobel, MD, explore avenues for confirming a diagnosis of RVVC, including cultures and molecular testing.
The Challenges of Diagnosing Recurrent Vulvovaginal Candidiasis
Michael L. Krychman, MD, and Jack D. Sobel, MD, review diagnostic criteria of diagnosis of RVVC and the impact of misdiagnosis.
Pathophysiology and Impact of Vulvovaginal Candidiasis
Michael L. Krychman, MD and Jack D. Sobel, MD, talk about the signs and symptoms of vulvovaginal candidiasis as well as its effect on patient quality of life.
New frontiers in sexual medicine
Top takeaways from ISSWSH 2022
Caring for women who are or have been incarcerated: contraception, sexual health, and trauma-informed care
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
First fungicidal medication for VVC approved by the FDA
In this video, Barb Dehn, NP, discusses Brexafemme, the first fungicidal medication approved for the treatment of vulvovaginal candidiasis.
S3 E19: Alyssa Dweck, MD, on menopause products, her podcast, and more
In this episode, Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist, and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.
Coping with COVID-19
Michael Krychman, MD discusses his perspective as a physician during the second wave of COVID-19, and shares some insight into ways other health care professionals can cope.
Building and sustaining a gender-affirming medical care environment
Angie DeRosa, Senior Editor at Contemporary OB/GYN®, interviewed Michael Krychman, MD, about the importance of creating an affirming environment in medical facilities for the LGBTQ+ community. He is the executive director of the Southern California Center for Sexual Health and Survivorship in Newport Beach, Calif.
2 Commerce Drive Cranbury, NJ 08512